DHART SPORE Developmental Research Program (DRP) & Career Enhancement Program (CEP) Awards
DHART SPORE Developmental Research Program (DRP) & Career Enhancement Program (CEP) Awards support researchers studying tumors in people with NF1 and other inherited Rasopathies to improve diagnosis and management.
Browse similar grants
Funder: Indiana Clinical and Translational Sciences Institute
Due Dates: November 3, 2026 (Submission deadline)
Funding Amounts: $50,000–$75,000 per award for 12 months; up to three DRP and three CEP projects
Summary: Supports basic, translational, and clinical research to improve tumor diagnosis and management in people with NF1 and other inherited Rasopathy syndromes.
Description
The Developmental and Hyperactive Ras Tumor (DHART) SPORE program aims to improve the diagnosis and management of tumors arising in people with neurofibromatosis type 1 (NF1) and other inherited “Rasopathy” syndromes. Offered through the Indiana Clinical and Translational Sciences Institute, these awards support basic, translational, and clinical research within that scientific focus.
Two funding opportunities are available: the Developmental Research Program (DRP) and the Career Enhancement Program (CEP). Both contribute to the DHART SPORE program’s broader effort to bring these areas of investigation together around tumors associated with inherited conditions. Each opportunity has separate guidelines and uses the DHART SPORE application and cover page.
